This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.

Recent news

Mass Device: Axoft completes first human cases with ultrasoft BCI

MedTech Insight: Potential For Soft Neural Implant To Help Coma Patients With Signs Of Brain Activity

Business Wire: Axoft to Begin Brain Implant Clinical Study

Neural Implant Podcast: Pioneering Neural Implant Materials with Axoft

Harvard SEAS news: A long-lasting neural probe

Axoft's work on soft neural interfaces was published in Nature Nanotechnology.

Axoft was nominated as Emerging MedTech Company of the Year by the New England Venture Capital Association!

Axoft has completed the Intel Ignite/US Deep-Tech accelerator program!

Axoft has graduated from the Creative Destruction Lab program!

Axoft Closes $8M Seed Financing led by The Engine and joins the FDA Breakthrough Device program

Co-Founder & scientific advisor Prof. Jia Liu was named Innovators Under 35 by the MIT Technology Review!

Forbes 30 under 30: CEO Dr. Paul Le Floch listed in the Science category

Materials Research Society: CEO Dr. Paul Le Floch awarded Graduate Student Gold Award

Axoft joins The Engine’s portfolio companies

Unparalleled access to neural code

Unparalleled access
to neural code